Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AK114 |
Synonyms | |
Therapy Description |
AK114 is a monoclonal antibody that targets IL-1b leading to inhibition of downstream signaling pathways and potentially resulting in decreased inflammatory response, angiogenesis, and tumor growth (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AK114 | AK-114|AK 114 | AK114 is a monoclonal antibody that targets IL-1b leading to inhibition of downstream signaling pathways and potentially resulting in decreased inflammatory response, angiogenesis, and tumor growth (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05200273 | Phase I | AK114 | A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 | Unknown status | AUS | 0 |